GlassScriptPhysician profile
Audrey Martinez
NPI 1811695158
$1,026.35
in general payments reported to CMS, 2019-2025
13 companies · $725 in 2025
The $725 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $88.17 · 2024: $213 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.36 |
| Education | $171.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $306.62 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $169.23 | 2024-2025 | |
| Abbvie INC. | $150.38 | 2023-2025 | |
| Lilly USA, LLC | $112.64 | 2024-2025 | Ebglyss, Taltz |
| Genzyme Corporation | $44.00 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $43.99 | 2024-2025 | Dupixent |
| Mayne Pharma Commercial LLC | $40.16 | 2023 | |
| Pfizer INC. | $38.55 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $28.40 | 2024 | Sotyktu |
| Exeltis, USA INC. | $27.76 | 2023 | Slynd |
| Amgen INC. | $22.29 | 2024 | Otezla |
| Arcutis Biotherapeutics, INC. | $21.90 | 2025 | Zoryve |
| Galderma Laboratories, L.P. | $20.43 | 2025 | Aklief |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.